RDNT:NSD-RadNet Inc. (USD)

EQUITY | Diagnostics & Research | NASDAQ Global Market

Last Closing

USD 48.4

Change

-0.45 (-0.92)%

Market Cap

USD 0.29B

Volume

0.29M

Analyst Target

USD 21.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

RadNet Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, and among others.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
IDXX IDEXX Laboratories Inc

+6.81 (+1.43%)

USD 41.47B
ICLR ICON PLC

-0.60 (-0.19%)

USD 25.49B
ILMN Illumina Inc

-6.16 (-5.18%)

USD 19.47B
MEDP Medpace Holdings Inc

+1.36 (+0.34%)

USD 12.27B
NTRA Natera Inc

-0.06 (-0.06%)

USD 11.20B
EXAS EXACT Sciences Corporation

-1.94 (-3.06%)

USD 10.68B
SHC Sotera Health Co

+0.18 (+1.59%)

USD 3.10B
OLK Olink Holding AB ADR

+0.07 (+0.30%)

USD 2.72B
NEOG Neogen Corporation

+0.27 (+2.22%)

USD 2.63B
GH Guardant Health Inc

-0.28 (-1.47%)

USD 1.96B

ETFs Containing RDNT

PSCH Invesco S&P SmallCap Heal.. 2.80 % 0.29 %

+0.35 (+0.89%)

USD 0.20B
WMCR 0.00 % 0.50 %

N/A

N/A
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

+0.79 (+0.89%)

USD 0.08B

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 39.20% 93% A 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.20% 93% A 89% A-
Trailing 12 Months  
Capital Gain 74.98% 89% A- 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.98% 89% A- 92% A
Trailing 5 Years  
Capital Gain 290.01% 93% A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 290.01% 93% A 93% A
Average Annual (5 Year Horizon)  
Capital Gain 32.32% 79% B- 86% B+
Dividend Return 32.32% 79% B- 86% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 51.19% 48% F 32% F
Risk Adjusted Return 63.14% 93% A 87% B+
Market Capitalization 0.29B 88% B+ 86% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 61.00 3% 1%
Price/Book Ratio 5.52 23% 20%
Price / Cash Flow Ratio 15.74 16% 17%
Price/Free Cash Flow Ratio 15.81 13% 17%
Management Effectiveness  
Return on Equity 4.65% 91% 65%
Return on Invested Capital 6.39% 92% 72%
Return on Assets 2.37% 91% 76%
Debt to Equity Ratio 128.76% 23% 18%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector